Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Quality Lowdown: FDA Defends Nitrosamine Testing Methods While US, EU Enforcement Continues

Jul 22 2020

• By Joanne S. Eglovitch

The Quality Lowdown

Related Content

US FDA Green-Lights Outsourcing Facilities, Pharmacies To Compound COVID-19 Treatments

Apr 29 2020

Dexamethasone COVID-19 Findings Leave Authorities Bracing for Yet Another Demand Surge

Jun 17 2020

FDA’s Scandal In Waiting?

Jun 10 2020

Enforcing A Belated Chemistry Lesson – The Nitrosamines In Sartans Saga

Aug 22 2019

New Testing Prompts New Finding Of NDMA, Cancer Risk In Metformin Products

May 31 2020

Related Companies

Sanofi

Additional Topics

Manufacturing Quality Enforcement BioPharmaceutical

More from Manufacturing

More from Compliance

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window